+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Japan
Publications
News & Events
Careers
Contact
[PSY80] A COMPARISON OF GDP-ADJUSTED ORPHAN DRUG PRICES IN 12 EUROPEAN COUNTRIES
Home
Publications
[PSY80] A COMPARISON OF GDP-ADJUSTED ORPHAN DRUG PRICES IN 12 EUROPEAN COUNTRIES
Back Home
[PSY80] A COMPARISON OF GDP-ADJUSTED ORPHAN DRUG PRICES IN 12 EUROPEAN COUNTRIES
2017 ISPOR 22nd Annual International Conference
Young, K.E. | Soussi, I. | Toumi, M. |
Volume: 20, Issue: 5, Pages: A223-A223,
